Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)
NCT03669822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97
Last updated 2025-01-24
Summary
Ulcerative colitis (UC) is a chronic, progressive immunologically mediated disease affecting nearly 1 million Americans. Up to one third of patients with UC will require hospitalization for severe disease (termed 'acute severe colitis (ASUC)'), often within the first year after diagnosis. Investigators will develop a large multi-center cohort of patients with ASUC with homogeneously collected detailed longitudinal clinical and laboratory data.
Conditions
Interventions
- OTHER
-
Standard of care
Care decisions driven by local physicians; this is an observational cohort.
Sponsors & Collaborators
-
Massachusetts General Hospital
collaborator OTHER - lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-10
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- United States
Study Locations
More Related Trials
-
Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis
NCT02569333 ·Status: COMPLETED ·Phase: NA
-
Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis
NCT02922374 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
NCT01078324 ·Status: COMPLETED
-
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
NCT02229344 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis
NCT06895252 ·Status: RECRUITING ·Phase: NA
-
MACCS: Multicenter Australian CE in Patients With Suspected Crohn's Disease Study
NCT00434551 ·Status: COMPLETED
-
Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
NCT02770040 ·Status: COMPLETED ·Phase: PHASE4
-
Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan
NCT05189327 ·Status: UNKNOWN
-
Early Serum Infliximab Levels in Severe Ulcerative Colitis.
NCT01971814 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)
NCT04700449 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis
NCT02277470 ·Status: UNKNOWN
-
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
NCT06257875 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Faecal Microbiota Transplantation in Ulcerative Colitis
NCT01896635 ·Status: COMPLETED ·Phase: PHASE2
-
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis
NCT03808506 ·Status: WITHDRAWN
-
Wireless Capsule Endoscopy in Ulcerative Colitis
NCT00145808 ·Status: COMPLETED ·Phase: PHASE3
-
Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis
NCT03609905 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Chronic Diarrhea Owing to Underlying Microscopic Colitis
NCT06530836 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
NCT06228352 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
NCT02435992 ·Status: COMPLETED ·Phase: PHASE3
-
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883 ·Status: RECRUITING
-
Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis
NCT07258771 ·Status: RECRUITING ·Phase: PHASE4
-
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
NCT03239704 ·Status: UNKNOWN ·Phase: NA
-
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533 ·Status: COMPLETED
-
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
NCT03765450 ·Status: ACTIVE_NOT_RECRUITING